Skip to main content

2014 | OriginalPaper | Buchkapitel

Simple Parameters Describing Gut Absorption and Lipid Dynamics in Relation to Glucose Metabolism During a Routine Oral Glucose Test

verfasst von : Andrea Tura, Giovanni Pacini

Erschienen in: Data-driven Modeling for Diabetes

Verlag: Springer Berlin Heidelberg

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

The oral glucose tolerance test (OGTT) is a simple and physiological test used for the diagnosis of diabetes and, more generally, for the assessment of the metabolic condition of an individual. For a deep analysis of the OGTT data, the exploitation of mathematical models for the interpretation of the test results is necessary. The focus of this chapter is on some recent models based on OGTT data, describing the glucose absorption from the gut, and the effects of insulin on the dynamics of non-esterified free fatty acids (NEFA). As regards the glucose absorption model, it requires measure of plasma glucose and insulin during the OGTT. The model allows the estimation of absorption rates, the total glucose absorbed, and half-life in the gastrointestinal tract. In fact, the increase of postprandial circulating plasma glucose over time is the result of gain from gut glucose absorption and liver endogenous glucose production, and loss because of glucose uptake, predominantly by skeletal muscle. Endogenous glucose production can be assessed by some mathematical expressions depending on plasma insulin values, whereas the glucose loss is calculated as a function of the endogenous glucose production and of the insulin sensitivity in each individual. Once these variables have been determined, glucose absorption can be determined by solving a nonlinear least squares problem fitting the plasma glucose values during the OGTT. The model was used to analyze sex related differences in OGTT glucose metabolism, including gut absorption, in healthy humans. We found that, in the early phase of the OGTT, males had markedly increased glucose absorption rates by approximately 200 mg/min from the gastrointestinal tract, whereas in the final phase of the OGTT, females absorbed approximately 60 mg/min more glucose. In another study, the model was used to assess glucose absorption in 15 pregnant women with gestational diabetes. As regards the model of NEFA dynamics, it was postulated that NEFA kinetics could be described by first order (single compartment) kinetics, with NEFA production controlled by insulin in remote compartment. It is assumed that plasma insulin enters a remote compartment, before having an inhibitory effect on NEFA production. Starting from basal production at basal insulin, NEFA production decreases, for suprabasal increase in remote insulin up to a prescribed value. The identification of the unknown parameters of the model was performed by applying Genetic Algorithms. The model was used to study NEFA kinetics in a group of women with a history of gestational diabetes (fGDM). The fGDM women were divided into normal glucose tolerance group (NGT) and a impaired glucose metabolism (IGM). We also studied 15 control (CNT) women. We found that, while fasting NEFA were not different between groups, IGM exhibited slower decline in plasma NEFA during the OGTT. We conclude that appropriate mathematical modeling allows sophisticated analyses of the OGTT data, thus possibly providing a comprehensive picture of the metabolic condition.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat American Diabetes Association (2013) Standards of medical care in diabetes—2013. Diabetes Care 36(Suppl. 1):S11–S66CrossRef American Diabetes Association (2013) Standards of medical care in diabetes—2013. Diabetes Care 36(Suppl. 1):S11–S66CrossRef
2.
Zurück zum Zitat American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl. 1):S67–S74CrossRef American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl. 1):S67–S74CrossRef
3.
Zurück zum Zitat Drucker D, Nauck M (2006) The incretin system: glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696–1705CrossRef Drucker D, Nauck M (2006) The incretin system: glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696–1705CrossRef
4.
Zurück zum Zitat Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24(3):539–548CrossRef Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24(3):539–548CrossRef
5.
Zurück zum Zitat Caumo A, Bergman RN, Cobelli C (2000) Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab 85:4396–4402CrossRef Caumo A, Bergman RN, Cobelli C (2000) Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab 85:4396–4402CrossRef
6.
Zurück zum Zitat Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C (2001) Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50:150–158CrossRef Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C (2001) Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 50:150–158CrossRef
7.
Zurück zum Zitat Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470CrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470CrossRef
8.
Zurück zum Zitat Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Häring H, Fritsche A, Gerich J (2000) Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes. Diabetes Care 23(9):1440–1441CrossRef Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Häring H, Fritsche A, Gerich J (2000) Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes. Diabetes Care 23(9):1440–1441CrossRef
9.
Zurück zum Zitat Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M (2007) The Clamp-like index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care 30(9):2374–2380CrossRef Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M (2007) The Clamp-like index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care 30(9):2374–2380CrossRef
10.
Zurück zum Zitat Hovorka R, Chassin L, Luzio SD, Playle R, Owens DR (1998) Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:744–750 Hovorka R, Chassin L, Luzio SD, Playle R, Owens DR (1998) Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:744–750
11.
Zurück zum Zitat Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modelling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl. 1):S221–S226CrossRef Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modelling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl. 1):S221–S226CrossRef
12.
Zurück zum Zitat Thomaseth K, Kautzky-Willer A, Ludvik B, Prager R, Pacini G (1996) Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am J Physiol 270(3 Pt 1):E522–E531 Thomaseth K, Kautzky-Willer A, Ludvik B, Prager R, Pacini G (1996) Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am J Physiol 270(3 Pt 1):E522–E531
13.
Zurück zum Zitat Cretti A, Lehtovirta M, Bonora E, Brunato B, Zenti MG, Tosi F, Caputo M, Caruso B, Groop LC, Muggeo M, Bonadonna RC (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416 Cretti A, Lehtovirta M, Bonora E, Brunato B, Zenti MG, Tosi F, Caputo M, Caruso B, Groop LC, Muggeo M, Bonadonna RC (2001) Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion. Eur J Clin Invest 31:405–416
14.
Zurück zum Zitat Mari A, Ferrannini E (2008) Beta-cell function assessment from modelling of oral tests: an effective approach. Diab Obes Metab 10(Suppl 4):77–87CrossRef Mari A, Ferrannini E (2008) Beta-cell function assessment from modelling of oral tests: an effective approach. Diab Obes Metab 10(Suppl 4):77–87CrossRef
15.
Zurück zum Zitat Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diab Res Clin Pract 72:298–301CrossRef Tura A, Kautzky-Willer A, Pacini G (2006) Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diab Res Clin Pract 72:298–301CrossRef
16.
Zurück zum Zitat Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A (2011) Shape of glucose, insulin, C-peptide curves during a 3 h oral glucose tolerance test: any relationship with the degree of glucose tolerance? Am J Physiol Regul Integr Comp Physiol 300:R941–R948CrossRef Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A (2011) Shape of glucose, insulin, C-peptide curves during a 3 h oral glucose tolerance test: any relationship with the degree of glucose tolerance? Am J Physiol Regul Integr Comp Physiol 300:R941–R948CrossRef
17.
Zurück zum Zitat Tura A, Pacini G, Kautzky-Willer A, Gastaldelli A, DeFronzo RA, Ferrannini E, Mari A (2012) Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models. Metabolism 61(3):434–443CrossRef Tura A, Pacini G, Kautzky-Willer A, Gastaldelli A, DeFronzo RA, Ferrannini E, Mari A (2012) Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models. Metabolism 61(3):434–443CrossRef
18.
Zurück zum Zitat Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 17(3):305–322CrossRef Pacini G, Mari A (2003) Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 17(3):305–322CrossRef
19.
Zurück zum Zitat Anderwald C, Gastaldelli A, Tura A, Krebs M, Promintzer-Schifferl M, Kautzky-Willer A, Stadler M, DeFronzo RA, Pacini G, Bischof MG (2011) Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab 96(2):515–524CrossRef Anderwald C, Gastaldelli A, Tura A, Krebs M, Promintzer-Schifferl M, Kautzky-Willer A, Stadler M, DeFronzo RA, Pacini G, Bischof MG (2011) Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab 96(2):515–524CrossRef
20.
Zurück zum Zitat van Tulder L, Michaeli B, Chiole′ro R, Berger MM, Revelly JP (2005) An evaluation of the initial distribution volume of glucose to assess plasma volume during a fluid challenge. Anesth Analg 101:1089–1093CrossRef van Tulder L, Michaeli B, Chiole′ro R, Berger MM, Revelly JP (2005) An evaluation of the initial distribution volume of glucose to assess plasma volume during a fluid challenge. Anesth Analg 101:1089–1093CrossRef
21.
Zurück zum Zitat Tura A, Sbrignadello S, Succurro E, Groop L, Sesti G, Pacini G (2010) An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia 53(1):144–152CrossRef Tura A, Sbrignadello S, Succurro E, Groop L, Sesti G, Pacini G (2010) An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia 53(1):144–152CrossRef
22.
Zurück zum Zitat Anderwald C, Tura A, Winhofer Y, Krebs M, Winzer C, Bischof MG, Luger A, Pacini G, Kautzky-Willer A (2011) Glucose absorption in gestational diabetes mellitus during an oral glucose tolerance test. Diabetes Care 34(7):1475–1480CrossRef Anderwald C, Tura A, Winhofer Y, Krebs M, Winzer C, Bischof MG, Luger A, Pacini G, Kautzky-Willer A (2011) Glucose absorption in gestational diabetes mellitus during an oral glucose tolerance test. Diabetes Care 34(7):1475–1480CrossRef
23.
Zurück zum Zitat Morbiducci U, Di Benedetto G, Kautzky-Willer A, Deriu MA, Pacini G, Tura A (2011) Identification of a model of non-esterified fatty acids dynamics through genetic algorithms: the case of women with a history of gestational diabetes. Comput Biol Med 41(3):146–153CrossRef Morbiducci U, Di Benedetto G, Kautzky-Willer A, Deriu MA, Pacini G, Tura A (2011) Identification of a model of non-esterified fatty acids dynamics through genetic algorithms: the case of women with a history of gestational diabetes. Comput Biol Med 41(3):146–153CrossRef
24.
Zurück zum Zitat Goldberg DE (1989) Genetic algorithms in search, optimization and machine learning. Addison Wesley, New YorkMATH Goldberg DE (1989) Genetic algorithms in search, optimization and machine learning. Addison Wesley, New YorkMATH
25.
Zurück zum Zitat Morbiducci U, Tura A, Grigioni M (2005) Genetic algorithms for parameter estimation in mathematical modeling of glucose metabolism. Comput Biol Med 35(10):862–874CrossRef Morbiducci U, Tura A, Grigioni M (2005) Genetic algorithms for parameter estimation in mathematical modeling of glucose metabolism. Comput Biol Med 35(10):862–874CrossRef
26.
Zurück zum Zitat Tura A, Pacini G, Winhofer Y, Bozkurt L, Di Benedetto G, Morbiducci U, Roden M, Kautzky-Willer A (2012) Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes. Diabet Med 29(3):351–358CrossRef Tura A, Pacini G, Winhofer Y, Bozkurt L, Di Benedetto G, Morbiducci U, Roden M, Kautzky-Willer A (2012) Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes. Diabet Med 29(3):351–358CrossRef
27.
Zurück zum Zitat Tura A, Ludvik B, Nolan JJ, Pacini G, Thomaseth K (2001) Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab 281(5):E966–E974 Tura A, Ludvik B, Nolan JJ, Pacini G, Thomaseth K (2001) Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab 281(5):E966–E974
28.
Zurück zum Zitat Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, Thomaseth K (2003) Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. Am J Physiol Endocrinol Metab 285(1):E155–E162 Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, Thomaseth K (2003) Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. Am J Physiol Endocrinol Metab 285(1):E155–E162
29.
Zurück zum Zitat Ludvik B, Thomaseth K, Nolan JJ, Clodi M, Prager R, Pacini G (2003) Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects. Eur J Clin Invest 33(4):316–322CrossRef Ludvik B, Thomaseth K, Nolan JJ, Clodi M, Prager R, Pacini G (2003) Inverse relation between amylin and glucagon secretion in healthy and diabetic human subjects. Eur J Clin Invest 33(4):316–322CrossRef
30.
Zurück zum Zitat Thomaseth K, Pacini G, Clodi M, Kautzky-Willer A, Nolan JJ, Prager R, Olefsky JM, Ludvik B (1997) Amylin release during oral glucose tolerance test. Diabet Med 14(Suppl 2):S29–S34CrossRef Thomaseth K, Pacini G, Clodi M, Kautzky-Willer A, Nolan JJ, Prager R, Olefsky JM, Ludvik B (1997) Amylin release during oral glucose tolerance test. Diabet Med 14(Suppl 2):S29–S34CrossRef
31.
Zurück zum Zitat Salinari S, Bertuzzi A, Mingrone G (2011) Intestinal transit of a glucose bolus and incretin kinetics: a mathematical model with application to the oral glucose tolerance test. Am J Physiol Endocrinol Metab 300(6):E955–E965CrossRef Salinari S, Bertuzzi A, Mingrone G (2011) Intestinal transit of a glucose bolus and incretin kinetics: a mathematical model with application to the oral glucose tolerance test. Am J Physiol Endocrinol Metab 300(6):E955–E965CrossRef
32.
Zurück zum Zitat Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E (2005) Beta-cell function in mild type 2 diabetic patients. Effects of 6-month glucose lowering with nateglinide. Diabetes Care 28:1132–1138CrossRef Mari A, Gastaldelli A, Foley JE, Pratley RE, Ferrannini E (2005) Beta-cell function in mild type 2 diabetic patients. Effects of 6-month glucose lowering with nateglinide. Diabetes Care 28:1132–1138CrossRef
33.
Zurück zum Zitat Ahrén B, Pacini G, Foley JE, Schweizer A (2005) Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. Diabetes Care 28:1936–1940CrossRef Ahrén B, Pacini G, Foley JE, Schweizer A (2005) Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. Diabetes Care 28:1936–1940CrossRef
34.
Zurück zum Zitat Ohlsson L, Alsalim W, Carr RD, Tura A, Pacini G, Mari A, Ahrén B (2013) Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects. Diabetes Obes Metab 15(6):531–537CrossRef Ohlsson L, Alsalim W, Carr RD, Tura A, Pacini G, Mari A, Ahrén B (2013) Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects. Diabetes Obes Metab 15(6):531–537CrossRef
Metadaten
Titel
Simple Parameters Describing Gut Absorption and Lipid Dynamics in Relation to Glucose Metabolism During a Routine Oral Glucose Test
verfasst von
Andrea Tura
Giovanni Pacini
Copyright-Jahr
2014
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-642-54464-4_7

Neuer Inhalt